Loading clinical trials...
Loading clinical trials...
To assess safety and efficacy of AL-15469A 0.5% /AL-6515 0.3% Ophthalmic Suspension for treatment of bacterial conjunctivitis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alcon Research
NCT02432807 · Bacterial Conjunctivitis
NCT00759148 · Bacterial Conjunctivitis
NCT00347932 · Acute Bacterial Conjunctivitis
NCT01330355 · Bacterial Conjunctivitis
NCT00972777 · Bacterial Conjunctivitis
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions